| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.64B | 12.63B | 12.49B | 12.21B | 12.37B | 11.79B |
| Gross Profit | 4.29B | 5.27B | 5.08B | 4.91B | 5.08B | 4.42B |
| EBITDA | 1.40B | 1.25B | 1.29B | 1.17B | 1.71B | 1.01B |
| Net Income | 329.00M | -516.00M | -133.00M | 46.00M | 230.00M | 511.00M |
Balance Sheet | ||||||
| Total Assets | 13.24B | 14.05B | 14.46B | 14.67B | 15.22B | 16.01B |
| Cash, Cash Equivalents and Short-Term Investments | 123.00M | 37.00M | 38.00M | 118.00M | 507.00M | 1.68B |
| Total Debt | 11.24B | 12.10B | 12.17B | 12.39B | 12.82B | 12.88B |
| Total Liabilities | 14.19B | 15.37B | 15.28B | 15.40B | 16.03B | 17.06B |
| Stockholders Equity | -1.50B | -1.91B | -1.39B | -1.37B | -1.37B | -1.63B |
Cash Flow | ||||||
| Free Cash Flow | 143.00M | 120.00M | -257.00M | -115.00M | -600.00M | 1.74B |
| Operating Cash Flow | 493.00M | 480.00M | 210.00M | 300.00M | -131.00M | 2.18B |
| Investing Cash Flow | 562.00M | -277.00M | -22.00M | -251.00M | -543.00M | 191.00M |
| Financing Cash Flow | -965.00M | -204.00M | -268.00M | -438.00M | -495.00M | -909.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $1.27B | 33.25 | 8.07% | ― | 6.26% | -19.33% | |
57 Neutral | $656.49M | -21.62 | -6.86% | ― | 12.48% | -9.28% | |
54 Neutral | $432.18M | 1.29 | ― | ― | 0.74% | ― | |
54 Neutral | $430.16M | ― | -2.10% | ― | 1.02% | 89.58% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | $606.17M | ― | -35.90% | ― | -11.42% | -617.31% | |
46 Neutral | $394.76M | -46.54 | -3.76% | ― | -22.14% | -787.87% |
On October 30, 2025, Community Health Systems, Inc. announced a definitive agreement to sell its 80% ownership interests in two joint ventures, which own and operate Tennova Healthcare – Clarksville and ancillary businesses, to Vanderbilt University Medical Center for $600 million. This transaction, expected to close in early 2026, is part of the company’s strategic divestitures and involves Vanderbilt purchasing the remaining ownership interests in these ventures. The deal is subject to regulatory approvals and closing conditions, and it highlights Community Health Systems’ ongoing efforts to streamline its operations and focus on core assets.
The most recent analyst rating on (CYH) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Community Health stock, see the CYH Stock Forecast page.
Community Health Systems (CHS) recently held its third-quarter earnings call, which revealed a mix of positive developments and ongoing challenges. The company reported revenue growth and a reduction in leverage, alongside an increase in employed physicians. However, it also faced challenges in outpatient surgeries, emergency department visits, and inflationary pressures. Despite these hurdles, CHS remains optimistic about achieving positive cash flow and continued growth.
Community Health Systems, Inc. announced its financial results for the third quarter ending September 30, 2025, reporting net operating revenues of $3.087 billion and a net income of $130 million, a significant improvement from the net loss in the same period in 2024. The company completed a refinancing initiative in August 2025, enhancing liquidity and supporting strategic initiatives, and announced divestitures and a definitive agreement with Labcorp to sell select assets, which are expected to impact its financial positioning and operations positively.
The most recent analyst rating on (CYH) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Community Health stock, see the CYH Stock Forecast page.
On September 30, 2025, Community Health Systems, Inc. announced that its retiring CEO, Tim L. Hingtgen, has entered into a consultancy agreement with the company. Effective October 1, 2025, Mr. Hingtgen will advise on healthcare operations and strategy until September 30, 2026, receiving a monthly fee while adhering to non-compete and conflict of interest restrictions.
The most recent analyst rating on (CYH) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on Community Health stock, see the CYH Stock Forecast page.
On September 10, 2025, Community Health Systems, Inc. announced the appointment of Kevin J. Hammons as Interim Chief Executive Officer, effective October 1, 2025, following the retirement of Tim L. Hingtgen. Concurrently, Jason K. Johnson was appointed as Interim Chief Financial Officer, replacing Hammons. These leadership changes, previously announced in July 2025, are accompanied by revised compensation arrangements for both executives, including increased base salaries and enhanced cash incentive opportunities tied to company performance goals for the remainder of 2025.
The most recent analyst rating on (CYH) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on Community Health stock, see the CYH Stock Forecast page.